LYKA LABS LTD. SHARE PRICE [LIVE]

BSE: INE933A01014   NSE: LYKALABS   SECTOR: Pharma

OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
129.70
Change:
BSE
131.00
Change:
NSE
BSE Click here to view BSE data
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality
Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Sector
Sensex
Name Mar 21 Dec 20

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in LYKA LABS LTD.

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

LYKALABS News

Frequently Asked Questions

What is the Share price of LYKA LABS LTD. (LYKALABS)?

LYKA LABS LTD. (LYKALABS) share price as of August 5, 2022, on NSE is Rs 129.70 (NSE) and Rs 131.00 (BSE) on BSE.

Can I buy LYKA LABS LTD. (LYKALABS) shares?

Yes, You can buy LYKA LABS LTD. (LYKALABS) shares by opening a Demat account with Angel One.

How do I buy LYKA LABS LTD. (LYKALABS) from Angel One?

LYKA LABS LTD. (LYKALABS) share can be brought through the following modes:
  1. Direct investment: You can buy LYKA LABS LTD. (LYKALABS) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to LYKA LABS LTD. (LYKALABS) shares.

In which sector do LYKA LABS LTD. (LYKALABS) belong?

LYKA LABS LTD. (LYKALABS) belongs to Pharma.

About LYKALABS

Today's live share price for LYKA LABS LTD. is NSE: ₹ 129.70, BSE: ₹ 131.00 with a current market capitalization of .

Initially manufacturing formulations, Lyka Labs brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr. '83. It also added a range of ayurvedic and animal health care products over the years. In 1990, it diversified into marketing medical and diagnostic equipment and instruments of Bekton Dickinson, US; Airsep Corporation, US; Coloplast, Denmark; and Terumo Corporation, Japan. Lyka Exports is the subsidiary of the company. The company offers a broad range of antibiotics used as life-savers and to treat minor infections. It has a fairly widespread product base with tropical steroids for skin disorders, anti-cancer products, cardio-vascular drugs and anti-inflammatory products. Lyka introduced, in India, cough lozenges containing dextromethorphan hydrobromide (DMR), favoured internationally as an effective and safe cough suppressant. Lyka has two formulations division and a bulk drugs division. It also set up additional manufacturing facilities for ointments. As part of its diversification, it has invested in Relic Finance, a company carrying on the business of finance and merchant banking. A GOI-recognised Export House, it received the Certificate of Merit for its excellent export performance in 1993-94. In the same year, it received an award from CHEMEXCIL for its outstanding performance. During 1997-98, the company's administrative office & plant at tarapur has been awarded ISO 9002 certification for its quality management system by SGS Yarsley International Certification Services Limited, UK. The production carried out at Bombay has been shifted to Tarapur and Ankleshwar in the year 1999-2000, inorder to achieve economies of scale and better compliance. The company has assigned Trade Marks and transferred technical, marketing know-how and allied rights pertaining to some of its products.

Read more